Excellasome

Excellasome is a regenerative medicine biologic developed by Olaregen Therapeutix, a subsidiary of Generex Biotechnology. It is designed as a combination therapy that integrates stem cell-derived exosomes (extracellular vesicles) with specific tissue engineering components to facilitate the repair and regeneration of musculoskeletal structures. The product targets conditions such as osteoarthritis, rheumatoid arthritis, cartilage defects, and plantar fasciitis. By utilizing the signaling capacity of exosomes, Excellasome aims to modulate the local environment, reduce inflammation, and stimulate endogenous repair mechanisms in bones and joints.

Brand names

Excellasome